Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Br J Haematol ; 145(2): 207-11, 2009 Apr.
Article in English | MEDLINE | ID: mdl-19236611

ABSTRACT

Aprotinin has been used widely in surgery as an anti-bleeding agent but is associated with a number of side effects. We report that textilinin-1, a serine protease inhibitor from Pseudonaja textilis venom with sequence relatedness to aprotinin, is a potent but reversible plasmin inhibitor and has a narrower range of protease inhibition compared to aprotinin. Like aprotinin, textilinin-1 at 5 micromol/l gave almost complete inhibition of tissue plasminogen activator-induced fibrinolysis of whole blood clots. The activated partial thromboplastin time for plasma was markedly increased by aprotinin but unaffected by textilinin-1. In a mouse tail-vein bleeding model, intravenous textilinin-1 and aprotinin caused similar decreases in blood loss but time to haemostasis in the textilinin-treated animals was significantly shorter than in aprotinin-treated mice. Based on these data, textilinin-1 merits further investigation as a therapeutic alternative to aprotinin.


Subject(s)
Aprotinin/therapeutic use , Blood Loss, Surgical/prevention & control , Elapid Venoms/therapeutic use , Fibrinolysin/antagonists & inhibitors , Serine Proteinase Inhibitors/therapeutic use , Analysis of Variance , Animals , Fibrinolysis/drug effects , Hemostasis , Mice , Time Factors
2.
Blood Coagul Fibrinolysis ; 17(5): 417-20, 2006 Jul.
Article in English | MEDLINE | ID: mdl-16788320

ABSTRACT

In-vitro experimentation was performed on porcine and human blood to determine their comparative responsiveness to a novel fibrinolytic inhibitor and thereby assess whether the pig is a suitable animal model for subsequent in-vivo testing of this inhibitor. Thromboelastography showed the clots formed from porcine whole blood to be highly resistant to tissue plasminogen activator (t-PA)-catalyzed lysis, and this communication offers the resistance of porcine plasminogen to activation by t-PA as an explanation. Porcine blood containing 100 and 1500 IU/ml added t-PA lysed very slowly, having LY30 values of 1.9 +/- 1.4 and 2.9 +/- 1.9%, respectively. In contrast, the LY30 values for the human clots containing 100 and 1500 IU/ml t-PA were 77.1 +/- 6.3 and 93.3 +/- 1.3%, respectively. Moreover, purified porcine plasminogen was activated very slowly by added t-PA in the presence of both human and porcine fibrin. Activation of plasminogen by the endogenous activators, as measured by the euglobulin clot lysis time, was greatly prolonged for the pig (22 +/- 3 h) compared with the human (3.5 +/- 1.5 h). These results suggest caution in using the pig as an experimental model when studying the effects of various agents on fibrinolysis.


Subject(s)
Fibrinolysis/drug effects , Fibrinolytic Agents/pharmacology , Thrombosis/prevention & control , Tissue Plasminogen Activator/therapeutic use , Animals , Enzyme Activation/drug effects , Enzyme Activation/physiology , Fibrinolytic Agents/metabolism , Humans , Models, Animal , Plasminogen/metabolism , Recombinant Proteins/pharmacology , Serum Globulins/chemistry , Serum Globulins/metabolism , Swine , Thrombelastography , Tissue Plasminogen Activator/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...